Skip to content

Factors Related to the Number of Visits to PT in PHC

Correlation Between Self-efficacy, Fear of Movement, Empowerment, Enablement and Number of Visits to Physiotherapist for Patients With Musculoskeletal Disorders in Primary Health Care: A Feasibility Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04375007
Enrollment
19
Registered
2020-05-05
Start date
2017-09-01
Completion date
2018-01-31
Last updated
2020-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases or Conditions

Keywords

Physiotherapy, Musculoskeletal disorders, Self-efficacy, Empowerment, Enablement

Brief summary

Musculoskeletal disorders can be a large burden on individuals, health care and social care systems. The aim was to assess the feasibility of performing a prospective study investigating whether self-efficacy, fear of movement, empowerment or enablement has any relation to the number of visits to physiotherapists among patients with a musculoskeletal disorder in primary health care. Design was apProspective study with consecutively selection including patients seeking physiotherapist for the first time for a musculoskeletal disorder. Primary outcome measure included operational and practical feasibility regarding recruitment of participants, use of questionnaires and key variables to be collected as part of the study.

Detailed description

Background: Musculoskeletal disorders can be a large burden on individuals, health care and social care systems. Patients with musculoskeletal disorders are often treated by physiotherapists in primary health care. Psychosocial variables can be a significant obstacle to recover from musculoskeletal injuries. The primary aim of this pilot study was to assess the feasibility of performing a prospective study investigating whether self-efficacy, fear of movement, empowerment or enablement has any relation to the number of visits to physiotherapist among patients with a musculoskeletal disorder in primary health care. Methods: Prospective study with consecutively selection including patients seeking physiotherapist for the first time for a musculoskeletal disorder. Primary outcome measure included operational and practical feasibility regarding recruitment of participants, use of questionnaires and key variables to be collected as part of the study. Secondary outcomes included correlation between self-efficacy (Exercise Self-Efficacy Scale (ESES-S)), fear of movement (Tampa Scale for Kinesiophobia (TSK-SV)), empowerment (Making Decisions Scale ), enablement (Patient Enablement Instrument (PEI)) and number of visits to physiotherapist. Statistical analysis was done using IBM SPSS statistics version 24 with analysis of correlation using Spearman's rank correlation coefficient.

Interventions

OTHERRoutine care

Physiotherapy intervention in routine care

Sponsors

Lund University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients, who seek physiotherapist for the first time for a musculoskeletal disorder, are over 18 years of age and are able to read, write and understand Swedish.

Exclusion criteria

* Patients, who have visited physiotherapist previous for the same musculoskeletal disorder and/or are diagnosed with malignant diseases. Patients, who suffer from dementia, severe mental illness or other conditions making them not able to understand the information about the study and not able to fill in the questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
RecruitmentThrough study completion, an average of 5 monthsRecruitment rate, time to recruit
Number of visitsThrough study completion, an average of 5 monthsCount

Secondary

MeasureTime frameDescription
Exercise self-efficacyAt baselineQuestionnarie
KinesiophobiaAt baselineQuestionnarie
EmpowermentAt baselineQuestionnaire
EnablementAt baselineQuestionnaire

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026